生命科学资讯

Arcus cancels work on Gilead-partnered cancer combo after trial setback

#SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more

Protein restriction reprograms the multi-organ proteomic landscape of mouse aging

Chutes & Ladders—Metabolic marketing master maneuvers to CEO

Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share

Arcus discontinues Gilead-partnered TIGIT trials due to futility

2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says

Leading the Way in Biotech Solutions Across Japan and Asia Pacific (JAPAC)

Arcus, Gilead report Phase 3 TIGIT failure in upper GI cancers

Strength in Technology Enabled Products Drives Roper: Can It Sustain? - The Globe and Mail

Praxis tees up another approval filing; Geron turns to layoffs

Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor

Amylyx pins its next hopes on a niche drug in the obesity space

GSK spins out corporate VC fund focused on bioelectronic tech

Agilent Technologies (A): Valuation Check After Earnings Beat, Analyst Upgrades, and Initial Share Price Pullback - Yahoo Finance

Agilent Technologies (A): Valuation Check After Earnings Beat, Analyst Upgrades, and Initial Share Price Pullback - Yahoo Finance UK

When two signals are better than one: Synergistic control of erythropoiesis

Identification of sporulation genes in Bacillus anthracis highlights similarities and significant differences with Bacillus subtilis

Derepression of the epithelial transcription factor GRHL2 promotes direct hepatocyte-to-cholangiocyte transdifferentiation

A metabolic atlas of the Klebsiella pneumoniae species complex reveals lineage-specific metabolism and capacity for intra-species co-operation